Ascendis Pharma (ASND) to Present Latest Clinical and Qualit

Ascendis Pharma (ASND) to Present Latest Clinical and Quality-of-Life Data for TransCon PTH-Treated Adults with Chronic Hypoparathyroidism

Ascendis Pharma (ASND) to Present Latest Clinical and Quality-of-Life Data for TransCon PTH-Treated Adults with Chronic Hypoparathyroidism

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Stockholm , Sweden , Japan , China , Denmark , Copenhagen , Køavn , Evisen , Vastra Gotalands Lan , United Kingdom , United States , Great Britain , Andrea Palermo , Aimee Shu , Peter Schwarz , Ascendis Pharma , Heide Siggelkow , Us Food Drug Administration , Endocrine Medical Sciences , Exchange Commission , Clinical Development , United Kingdom Medicines Healthcare Products Regulatory Agency , Teijin Ltd , European Congress , European Commission , Senior Vice President , Endocrine Medical , Presentationsustained Improvement , Renal Function , Chronic Hypoparathyroidism , Year Results , Replacing What , Current Management , Year Renal , Reported Outcomes , Initial Data , Compassionate Use , European Economic Area , Healthcare Products Regulatory Agency , Drug Administration , New Drug Application , Looking Statements This , Ascendi Annual Report ,